INSIGHTS ON CLINICAL TRIAL DESIGN

• Building Trust Through Connection: EmVenio At The Atlanta Black Expo

  Engaging with communities in familiar settings helps raise awareness, address concerns, and create a more inclusive foundation for clinical research participation built on dialogue, respect, and long‑term relationships.

• Bringing Clinical Trials To Everyone's Backyard

  Learn how bringing clinical trials to any community around the world is not only possible but also increases patient access and reach and improves recruitment and retention.

• Beyond The Database: Reaching Real Patients In Real Communities

  There’s fatigue around “database-only” recruitment tactics. This presentation spotlights how patient-centric, local engagement are outperforming traditional pipelines.

• RTSM Rescue Studies Are On The Rise

  As RTSM technology continues to evolve, clinical trial rescues are becoming increasingly common. Explore the rise of the rescue trend and why more sponsors are ready to change course.

• The Role Of FDA Initiatives In Early-Phase Oncology Trials

  5/15/2025

  Project FrontRunner represents a paradigm shift in oncology drug development, championing earlier-line studies to bring novel treatments to patients sooner.

• Human Abuse Potential: Selecting A Positive Control

  5/8/2026

  Choosing an effective positive control in HAP studies is critical but not always straightforward. Learn how to justify comparator and dose selection.

• Wearable Data Is Only Useful If It's There: Helping You Collect Your Study Data

  9/15/2025

  New, proactive alerts on this digital health platform ensure complete and high-quality data collection from wearable devices in clinical trials.

• Overcoming Challenges In Obesity Trials

  2/12/2026

  Obesity trials face high dropout rates due to long durations and complex requirements. Overcome these hurdles with personalized engagement, expert lifestyle support, and proactive patient care.

• Five Integration Pillars To Redefine Frontline Patient Engagement And Safety Operations

  8/20/2026

  Siloed medical information, patient support, product quality, and pharmacovigilance functions, alongside increasing biopharmaceutical complexity, require a unified operating model to meet modern demand.